Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irrisept vs saline for wound irrigation in posterior spine surgery
NCT05408923Phase 4Withdrawn
- Sponsor
- University of Missouri
- Start
- Jul 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Irrisept in surgical site infection (SSI), sponsored by University of Missouri. Primary endpoint: Surgical site infection incidence at 90 days. Planned start Jul 2022; status: withdrawn.
02
Drugs
Irrisept
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05408923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05408923.